Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FDJ59
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,886
Award facts
- Contract value 100% obligated
- $13,886.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,886.20 to DMS Pharmaceutical Group Inc. on May 20, 2025, for the supply of Nexplanon 68 mg implants. This award represents a firm fixed-price delivery order with an ultimate completion date of June 11, 2025, to be delivered to Park Ridge, Illinois. The contract includes no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a woman-owned small business. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies.
DMS Pharmaceutical Group Inc., a pharmaceutical wholesaler based in Park Ridge, Illinois, and registered in SAM.gov since 2001, serves as a critical supplier in the federal pharmaceutical supply chain. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. Nexplanon implants, a subdermal contraceptive device, represent one of the specialized pharmaceutical products within the company's extensive portfolio of deliveries to military health facilities. The firm's consistent success in securing federal contracts reflects its established capabilities in pharmaceutical distribution and its strategic positioning as a reliable supplier supporting military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB25FDJ59?
SPE2DB25FDJ59 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 20, 2025.
How much is contract SPE2DB25FDJ59 worth?
The government has obligated $13,886 on SPE2DB25FDJ59.
Is contract SPE2DB25FDJ59 an order under another contract?
Yes. SPE2DB25FDJ59 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDJ59 competed?
The extent of competition for SPE2DB25FDJ59 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award